STOCK TITAN
  1. Home
  2. Sec-filings
  3. BCTX
  4. [EFFECT] BriaCell Therapeutics Corp. SEC Filing

[EFFECT] BriaCell Therapeutics Corp. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 13, 2026 5:00 P.M.
Form: S-1
CIK: 0001610820
Company Name: BriaCell Therapeutics Corp.
File Number: 333-292388

Source: View Original Filing on SEC EDGAR

Stock BCTX logo
Briacell Therapeutics Corp

NASDAQ:BCTX

BCTX Rankings

#5925 Ranked by Market Cap
N/A Ranked by Dividends

BCTX Latest News

Jan 13, 2026
BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient
Dec 18, 2025
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine
Dec 10, 2025
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
Dec 9, 2025
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
Dec 2, 2025
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

BCTX Latest SEC Filings

Feb 26, 2026
[25-NSE] BriaCell Therapeutics Corp. SEC Filing
Feb 20, 2026
[8-K] BriaCell Therapeutics Corp. Reports Material Event
Feb 12, 2026
[DEF 14A] BriaCell Therapeutics Corp. Definitive Proxy Statement
Jan 23, 2026
[SCHEDULE 13G] BriaCell Therapeutics Corp. Passive Investment Disclosure (>5%)
Jan 15, 2026
[8-K] BriaCell Therapeutics Corp. Reports Material Event

BCTX Stock Data

29.15M
7.23M
Biotechnology
Pharmaceutical Preparations
Link
Canada
WEST VANCOUVER